KHINDIVI
Live / Allowed — Published for opposition (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98740770
- Mark type
- Stylized text
- Filed
- 09 Sept 2024
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Andrew D. Bochner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic disorders, respiratory diseases, hematologic disorders, neoplastic diseases, edematous disorders, gastrointestinal diseases, tuberculous meningitis infections and trichinosis infections
Owner
- Eton Pharmaceuticals, Inc., Deer Park, IL, US
- Eton Pharmaceuticals, Inc., Deer Park, IL, US
Prosecution history
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Dec 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 28 Oct 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 28 Oct 2025 — LETTER OF SUSPENSION E-MAILED
- 28 Oct 2025 — SUSPENSION LETTER WRITTEN
- 27 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Oct 2025 — ASSIGNED TO LIE
- 17 Oct 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 13 Jun 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED